查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1930052

全球糖尿病足溃疡治疗市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察以及未来预测（2025-2034）

Diabetic Foot Ulcer Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 160 Pages | 商品交期: 请询问到货日

价格

糖尿病足溃疡治疗市场成长因素

2025年全球糖尿病足溃疡（DFU）治疗市场规模将达93.6亿美元，预计2026年成长至99.2亿美元。到2034年，该市场预计将达到163.6亿美元，2026年至2034年的年复合成长率（CAGR）为6.44%。北美地区在2025年占据市场主导地位，市场占有率达38.88%。这主要归因于糖尿病足溃疡的高发病率、人们对早期治疗意识的不断提高以及为引进先进治疗方案而开展的合作不断扩大。

糖尿病足溃疡是第1型和第2型糖尿病患者常见的併发症，其特征是足部出现难以癒合的伤口。这些溃疡可能导致严重的感染，严重时甚至需要截肢。糖尿病足溃疡治疗市场包括先进的伤口敷料，例如抗菌敷料、水凝胶敷料和泡沫敷料；伤口护理设备，例如负压伤口治疗（NPWT）和高压氧治疗（HBOT）；主动治疗，例如皮肤移植替代物；以及辅助产品，例如负重装置。

市场驱动因素

该市场的成长主要受糖尿病及其相关足溃疡盛行率上升的驱动。全球每年约有1860万人受到影响，其中包括美国的160万人，显示市场对先进治疗方法的需求很高。人口老化、生活方式改变以及肥胖症的流行也导致了糖尿病足溃疡（DFU）发病率的上升。

技术进步和创新产品的推出也在推动市场成长。例如，Smith+Nephew于2024年4月推出了RENASYS EDGE负压伤口治疗系统，这是一款用于治疗慢性伤口的紧凑型家用护理设备。同样，用于皮肤移植的生长因子等生物活性疗法也在促进伤口癒合，缩短恢復时间。

市场限制因子

先进的DFU治疗费用高昂，伤口恢復期长，仍是挑战。严重的溃疡可能需要长达190天才能癒合，这增加了患者和医疗保健系统的经济负担。然而，已开发国家的政府偿付政策缓解一些经济压力，并支持治疗产品的推广应用。

市场趋势

市场正逐渐从传统的伤口管理产品转向先进的产品。先进的伤口护理敷料，包括水胶体敷料、水凝胶敷料和抗菌敷料，透过维持最佳的湿润环境和控制感染，促进伤口更快癒合。各大公司加大研发投入和推出新产品，更加速了这些敷料的普及。例如，Varco Leg Care 于2023年 12月推出了 "Ulsr Soothe Max" ，目的是有效治疗糖尿病足溃疡和静脉曲张溃疡。

依细分市场分析

依溃疡类型划分：市场分为神经源性缺血性溃疡、神经性溃疡、缺血性溃疡。由于神经源性缺血性溃疡的高发生率以及若不及时治疗可能导致严重併发症，预计到2026年，该细分市场将占据 58.45%的最大市场占有率。由于糖尿病患者常伴随週边神经病变和周边动脉疾病，神经性溃疡和缺血性溃疡仍将占据相当大的市场占有率。

依产品划分：伤口护理敷料预计到2026年将占据最大的市场占有率，达到42.42%，这主要得益于其易用性、有效的渗出液管理和加速癒合。伤口护理器材和主动治疗产品预计将稳定成长，其中主动治疗产品预计将呈现最高的年复合成长率，这主要归功于人们对生物活性和先进疗法的认知度和接受度不断提高。

依最终用户划分：医院预计到2026年将占据最大的市场占有率，达到39.48%，这反映了患者更倾向于在临床环境中接受专业护理。由于医疗保健支出增加、偿付政策以及创新家庭医疗保健疗法（例如2022年获得中国国家药品监督管理局批准的局部伤口氧疗（TWO2）疗法）的出现，诊所、门诊手术中心和家庭医疗保健机构也经历成长。

区域展望

北美将引领市场，2025年市场规模将达36.4亿美元。预计到2026年，美国市场规模将达到35.6亿美元，主要得益于高盛行率、先进的医疗保健基础设施以及合作措施。欧洲将占据第二大市场占有率，预计到2026年，英国和德国的市场规模将分别达到3.4亿美元和7亿美元。亚太地区预计将实现最高的年复合成长率，这主要得益于人口老化、生活方式的改变以及日本、中国和印度等主要企业的扩张。儘管拉丁美洲和中东及非洲的市场占有率较小，但由于监管审批的增加和医疗保健支出的扩大，预计这些地区的市场将实现成长。

本报告详细概述了糖尿病足溃疡（DFU）治疗市场。报告涵盖市场驱动因素、限制因素、趋势、按溃疡类型、产品类型和最终用户划分的市场细分、区域分析和竞争格局，以及对医疗保健支出、盛行率和监管审批的深入分析。报告也聚焦在新冠疫情的影响以及疫情后市场的復苏情况。

市场成长的主要驱动因素是糖尿病及相关足部溃疡发病率的上升、老年人口的成长、生活方式的改变以及先进伤口护理产品的日益普及。负压伤口治疗（NPWT）系统、水凝胶和抗菌敷料以及生物活性疗法等技术进步改善治疗效果、提高患者依从性并缩短復原时间。

从传统伤口管理向先进伤口管理的转变，以及家庭护理疗法（例如局部伤口氧疗（TWO2）系统）的日益普及，扩大市场覆盖范围。虽然高昂的治疗费用和较长的癒合时间带来了挑战，但已开发地区的偿付政策和不断成长的医疗保健支出缓解这些限制。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 2025年各国糖尿病足溃疡（DFU）盛行率
  • 2025年各国糖尿病足溃疡（DFU）治疗费用
  • 2025年各国伤口护理经济负担
  • 主要公司新产品发布
  • 关键产业趋势：併购（併购），合作
  • COVID-19 对全球糖尿病足溃疡治疗市场的影响

第5章 全球糖尿病足溃疡治疗市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依溃疡类型划分
    • 神经性溃疡
    • 缺血性溃疡
    • 神经缺血性溃疡
  • 市场分析、洞察与预测：依产品划分
    • 伤口护理敷料
      • 抗菌敷料
      • 泡棉敷料
      • 薄膜敷料
      • 藻酸盐敷料
      • 水凝胶敷料
      • 其他敷料
    • 伤口护理设备
      • 负压伤口护理非週边伤口治疗（NPWT）
      • 超音波疗法
      • 高压氧疗法（HBOT）
      • 其他
    • 主动疗法
      • 皮肤移植与替代疗法
      • 生长因子
      • 其他
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 医院
    • 诊所
    • 门诊手术中心
    • 家庭医疗保健
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美糖尿病足溃疡治疗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲糖尿病足溃疡治疗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区

第8章 亚太地区糖尿病足溃疡治疗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 东南亚
    • 亚太其他地区

第9章 拉丁美洲糖尿病足溃疡治疗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

    第10章 中东与非洲糖尿病足溃疡治疗市场分析：洞察与预测（2021-2034）

    • 依国家划分
      • GCC
      • 南非
      • 其他地区中东和非洲地区

    第11章 竞争分析

    • 全球市场占有率分析（2025年）
    • 公司简介
    • Coloplast A/S
    • Smith+Nephew
    • 3M
    • Convatec Inc.
    • Integra LifeSciences
    • B. Braun SE
    • Cardinal Health
    • Molnlycke Health Care AB
    • Essity Aktiebolag（publ）.
Product Code: FBI101948

Growth Factors of diabetic foot ulcer (DFU) treatment Market

The global diabetic foot ulcer (DFU) treatment market was valued at USD 9.36 billion in 2025 and is expected to grow to USD 9.92 billion in 2026. By 2034, the market is projected to reach USD 16.36 billion, registering a CAGR of 6.44% from 2026 to 2034. North America dominated the market in 2025 with a 38.88% share, fueled by the high prevalence of diabetic foot ulcers, rising awareness for early treatment, and growing collaborations to launch advanced treatment solutions.

Diabetic foot ulcers are common complications in patients with type 1 and type 2 diabetes, characterized by non-healing wounds typically on the feet. These ulcers can lead to severe infections and, in extreme cases, amputation. The DFU treatment market includes advanced wound dressings such as antimicrobials, hydrogel, and foam dressings, wound-care devices including negative pressure wound therapy (NPWT) and hyperbaric oxygen therapy (HBOT), active therapies like skin graft substitutes, and supportive products such as offloading devices.

Market Drivers

The market is primarily driven by the rising prevalence of diabetes and related foot ulcers. Globally, about 18.6 million people are affected annually, including 1.6 million in the U.S., highlighting the significant demand for advanced treatment options. The growing geriatric population, lifestyle changes, and obesity further contribute to the increasing incidence of DFUs.

Technological advancements and the introduction of innovative products also drive market growth. For instance, Smith+Nephew launched the RENASYS EDGE NPWT system in April 2024, a compact, homecare-friendly device for chronic wound treatment. Similarly, bioactive therapies such as skin grafting growth factors are enhancing wound healing and reducing recovery times.

Market Restraints

The high cost of advanced DFU treatments and the longer duration of wound recovery remain challenges. Severe ulcers can take up to 190 days to heal, increasing the economic burden on patients and healthcare systems. However, government reimbursement policies in developed countries mitigate some financial constraints, supporting the adoption of treatment products.

Market Trends

There is a shift from traditional to advanced wound management products. Advanced wound care dressings, including hydrocolloids, hydrogels, and antimicrobial dressings, promote faster healing by maintaining optimal moisture balance and controlling infections. Increasing R&D initiatives and product launches by key players further accelerate adoption. For example, Varco Leg Care launched Ulsr Soothe Max in December 2023, designed to treat DFUs and varicose vein ulcers efficiently.

Segmentation Analysis

By Ulcer Type: The market is segmented into neuro-ischemic, neuropathic, and ischemic ulcers. The neuro-ischemic segment dominated in 2026 with a 58.45% share, due to its prevalence and risk of severe complications if untreated. Neuropathic and ischemic ulcers also hold significant shares, driven by peripheral neuropathy and peripheral artery disease among diabetic patients.

By Product: Wound-care dressings accounted for the largest share in 2026 at 42.42%, due to ease of use, effective exudate management, and faster healing. Wound-care devices and active therapies are expected to grow steadily, with active therapies showing the highest CAGR due to increased awareness and adoption of bioactive and advanced treatment options.

By End-user: Hospitals held the largest share of 39.48% in 2026, reflecting patient preference for skilled care in clinical settings. Clinics, ambulatory surgical centers, and home care settings are also witnessing growth due to rising healthcare expenditure, reimbursement policies, and innovative homecare therapies such as Topical Wound Oxygen (TWO2) therapy approved by China's NMPA in 2022.

Regional Insights

North America led with a market size of USD 3.64 billion in 2025, with the U.S. projected to reach USD 3.56 billion by 2026, supported by high prevalence, advanced healthcare infrastructure, and collaborative initiatives. Europe held the second-largest share, with the U.K. and Germany projected to reach USD 0.34 billion and USD 0.7 billion respectively by 2026. Asia Pacific is expected to register the highest CAGR, driven by a rising geriatric population, lifestyle changes, and expansion by key players in Japan, China, and India. Latin America and the Middle East & Africa hold smaller shares but are expected to grow due to increased regulatory approvals and healthcare expenditure.

Competitive Landscape

The market is highly fragmented, with key players such as 3M, Smith+Nephew, Molnlycke Health Care AB, Cardinal Health, B. Braun SE, Convatec Inc., and Integra LifeSciences focusing on product innovation, strategic collaborations, acquisitions, and expanding global footprints. Recent developments include 3M FDA approvals in 2023 for advanced Veraflo Therapy dressings and Convatec's acquisition of Triad Life Sciences in 2022 to strengthen their biologics portfolio.

Report Coverage

The report provides a detailed overview of the DFU treatment market, including market drivers, restraints, trends, segmentation by ulcer type, product, and end-user, regional analysis, and competitive landscape, along with insights on healthcare expenditure, prevalence, and regulatory approvals. It also highlights the impact of COVID-19 and the recovery of the market post-pandemic.

Conclusion

The global diabetic foot ulcer treatment market, valued at USD 9.36 billion in 2025, is projected to grow to USD 9.92 billion in 2026 and reach USD 16.36 billion by 2034, reflecting a CAGR of 6.44% from 2026 to 2034. North America continues to lead the market, supported by the high prevalence of DFUs, advanced healthcare infrastructure, growing awareness for early intervention, and collaborative initiatives to launch innovative treatment solutions.

Market growth is primarily driven by the rising incidence of diabetes and associated foot ulcers, the expanding geriatric population, lifestyle changes, and increasing adoption of advanced wound care products. Technological advancements, including NPWT systems, hydrogel and antimicrobial dressings, and bioactive therapies, have enhanced treatment effectiveness, improved patient compliance, and shortened recovery times.

The shift from traditional to advanced wound management and the growing adoption of homecare-based therapies, such as Topical Wound Oxygen (TWO2) systems, are expanding market accessibility. While the high cost of treatment and longer healing durations pose challenges, reimbursement policies and increasing healthcare expenditure in developed regions mitigate these constraints.

Segmentation By Ulcer Type

  • Neuropathic Ulcer
  • Ischemic Ulcers
  • Neuro-ischemic Ulcer

By Product

  • Wound-care Dressings
    • Antimicrobial Dressings
    • Foam Dressings
    • Film Dressings
    • Alginate Dressings
    • Hydrogel Dressings
    • Other Dressings
  • Wound-care Devices
    • Negative Pressure Wound Therapy (NPWT)
    • Ultrasound Therapy
    • Hyperbaric Oxygen Therapy (HBOT)
    • Others
  • Active Therapies
    • Skin Grafts & Substitutes
    • Growth Factors
    • Others
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

By Region

  • North America (By Ulcer Type, By Product, By End User, and By Country)
    • U.S.
    • Canada
  • Europe (By Ulcer Type, By Product, By End User, and By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Ulcer Type, By Product, By End User, and By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Ulcer Type, By Product, By End User, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa ( By Ulcer Type, By Product, By End User, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Diabetic Foot Ulcer (DFU) Patients, By Key Countries, 2025
  • 4.2. Cost of Diabetic Foot Ulcer (DFU) Treatment, By Key Countries, 2025
  • 4.3. Economic Cost Burden, Wound Care, By Key Countries, 2025/2025
  • 4.4. New Product Launches, By Key Players
  • 4.5. Key Industry Developments: Mergers, Acquisitions, Partnerships
  • 4.6. Impact of COVID-19 on the Global Diabetic Foot Ulcer Treatment Market

5. Global Diabetic Foot Ulcer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Ulcer Type
    • 5.1.1. Neuropathic Ulcer
    • 5.1.2. Ischemic Ulcers
    • 5.1.3. Neuro-Ischemic Ulcer
  • 5.2. Market Analysis, Insights and Forecast - By Product
    • 5.2.1. Wound-care Dressings
      • 5.2.1.1. Antimicrobial Dressings
      • 5.2.1.2. Foam Dressings
      • 5.2.1.3. Film Dressings
      • 5.2.1.4. Alginate Dressings
      • 5.2.1.5. Hydrogel Dressings
      • 5.2.1.6. Other Dressings
    • 5.2.2. Wound-care Devices
      • 5.2.2.1. Negative Pressure Wound Therapy (NPWT)
      • 5.2.2.2. Ultrasound Therapy
      • 5.2.2.3. Hyperbaric Oxygen Therapy (HBOT)
      • 5.2.2.4. Others
    • 5.2.3. Active Therapies
      • 5.2.3.1. Skin Grafts & Substitutes
      • 5.2.3.2. Growth Factors
      • 5.2.3.3. Others
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Clinics
    • 5.3.3. Ambulatory Surgical Centers
    • 5.3.4. Homecare Settings
  • 5.4. Market Analysis, Insights and Forecast - Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Diabetic Foot Ulcer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Ulcer Type
    • 6.1.1. Neuropathic Ulcer
    • 6.1.2. Ischemic Ulcers
    • 6.1.3. Neuro-Ischemic Ulcer
  • 6.2. Market Analysis, Insights and Forecast - By Product
    • 6.2.1. Wound-care Dressings
      • 6.2.1.1. Antimicrobial Dressings
      • 6.2.1.2. Foam Dressings
      • 6.2.1.3. Film Dressings
      • 6.2.1.4. Alginate Dressings
      • 6.2.1.5. Hydrogel Dressings
      • 6.2.1.6. Other Dressings
    • 6.2.2. Wound-care Devices
      • 6.2.2.1. Negative Pressure Wound Therapy (NPWT)
      • 6.2.2.2. Ultrasound Therapy
      • 6.2.2.3. Hyperbaric Oxygen Therapy (HBOT)
      • 6.2.2.4. Others
    • 6.2.3. Active Therapies
      • 6.2.3.1. Skin Grafts & Substitutes
      • 6.2.3.2. Growth Factors
      • 6.2.3.3. Others
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Clinics
    • 6.3.3. Ambulatory Surgical Centers
    • 6.3.4. Homecare Settings
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Diabetic Foot Ulcer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Ulcer Type
    • 7.1.1. Neuropathic Ulcer
    • 7.1.2. Ischemic Ulcers
    • 7.1.3. Neuro-Ischemic Ulcer
  • 7.2. Market Analysis, Insights and Forecast - By Product
    • 7.2.1. Wound-care Dressings
      • 7.2.1.1. Antimicrobial Dressings
      • 7.2.1.2. Foam Dressings
      • 7.2.1.3. Film Dressings
      • 7.2.1.4. Alginate Dressings
      • 7.2.1.5. Hydrogel Dressings
      • 7.2.1.6. Other Dressings
    • 7.2.2. Wound-care Devices
      • 7.2.2.1. Negative Pressure Wound Therapy (NPWT)
      • 7.2.2.2. Ultrasound Therapy
      • 7.2.2.3. Hyperbaric Oxygen Therapy (HBOT)
      • 7.2.2.4. Others
    • 7.2.3. Active Therapies
      • 7.2.3.1. Skin Grafts & Substitutes
      • 7.2.3.2. Growth Factors
      • 7.2.3.3. Others
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Ambulatory Surgical Centers
    • 7.3.4. Homecare Settings
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Diabetic Foot Ulcer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Ulcer Type
    • 8.1.1. Neuropathic Ulcer
    • 8.1.2. Ischemic Ulcers
    • 8.1.3. Neuro-Ischemic Ulcer
  • 8.2. Market Analysis, Insights and Forecast - By Product
    • 8.2.1. Wound-care Dressings
      • 8.2.1.1. Antimicrobial Dressings
      • 8.2.1.2. Foam Dressings
      • 8.2.1.3. Film Dressings
      • 8.2.1.4. Alginate Dressings
      • 8.2.1.5. Hydrogel Dressings
      • 8.2.1.6. Other Dressings
    • 8.2.2. Wound-care Devices
      • 8.2.2.1. Negative Pressure Wound Therapy (NPWT)
      • 8.2.2.2. Ultrasound Therapy
      • 8.2.2.3. Hyperbaric Oxygen Therapy (HBOT)
      • 8.2.2.4. Others
    • 8.2.3. Active Therapies
      • 8.2.3.1. Skin Grafts & Substitutes
      • 8.2.3.2. Growth Factors
      • 8.2.3.3. Others
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Ambulatory Surgical Centers
    • 8.3.4. Homecare Settings
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Diabetic Foot Ulcer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Ulcer Type
    • 9.1.1. Neuropathic Ulcer
    • 9.1.2. Ischemic Ulcers
    • 9.1.3. Neuro-Ischemic Ulcer
  • 9.2. Market Analysis, Insights and Forecast - By Product
    • 9.2.1. Wound-care Dressings
      • 9.2.1.1. Antimicrobial Dressings
      • 9.2.1.2. Foam Dressings
      • 9.2.1.3. Film Dressings
      • 9.2.1.4. Alginate Dressings
      • 9.2.1.5. Hydrogel Dressings
      • 9.2.1.6. Other Dressings
    • 9.2.2. Wound-care Devices
      • 9.2.2.1. Negative Pressure Wound Therapy (NPWT)
      • 9.2.2.2. Ultrasound Therapy
      • 9.2.2.3. Hyperbaric Oxygen Therapy (HBOT)
      • 9.2.2.4. Others
    • 9.2.3. Active Therapies
      • 9.2.3.1. Skin Grafts & Substitutes
      • 9.2.3.2. Growth Factors
      • 9.2.3.3. Others
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Clinics
    • 9.3.3. Ambulatory Surgical Centers
    • 9.3.4. Homecare Settings
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Diabetic Foot Ulcer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Ulcer Type
    • 10.1.1. Neuropathic Ulcer
    • 10.1.2. Ischemic Ulcers
    • 10.1.3. Neuro-Ischemic Ulcer
  • 10.2. Market Analysis, Insights and Forecast - By Product
    • 10.2.1. Wound-care Dressings
      • 10.2.1.1. Antimicrobial Dressings
      • 10.2.1.2. Foam Dressings
      • 10.2.1.3. Film Dressings
      • 10.2.1.4. Alginate Dressings
      • 10.2.1.5. Hydrogel Dressings
      • 10.2.1.6. Other Dressings
    • 10.2.2. Wound-care Devices
      • 10.2.2.1. Negative Pressure Wound Therapy (NPWT)
      • 10.2.2.2. Ultrasound Therapy
      • 10.2.2.3. Hyperbaric Oxygen Therapy (HBOT)
      • 10.2.2.4. Others
    • 10.2.3. Active Therapies
      • 10.2.3.1. Skin Grafts & Substitutes
      • 10.2.3.2. Growth Factors
      • 10.2.3.3. Others
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Clinics
    • 10.3.3. Ambulatory Surgical Centers
    • 10.3.4. Homecare Settings
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Coloplast A/S
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Smith+Nephew
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. 3M
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Convatec Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Integra LifeSciences
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. B. Braun SE
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Cardinal Health
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Molnlycke Health Care AB
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Essity Aktiebolag (publ).
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Ulcer Type, 2021-2034
  • Table 2: Global Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 3: Global Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Dressings, 2021-2034
  • Table 4: Global Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Devices, 2021-2034
  • Table 5: Global Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Active Therapies, 2021-2034
  • Table 6: Global Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Ulcer Type, 2021-2034
  • Table 9: North America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 10: North America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Dressings, 2021-2034
  • Table 11: North America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Devices, 2021-2034
  • Table 12: North America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Active Therapies, 2021-2034
  • Table 13: North America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Ulcer Type, 2021-2034
  • Table 16: Europe Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 17: Europe Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Dressings, 2021-2034
  • Table 18: Europe Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Devices, 2021-2034
  • Table 19: Europe Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Active Therapies, 2021-2034
  • Table 20: Europe Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 21: Europe Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Ulcer Type, 2021-2034
  • Table 23: Asia Pacific Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 24: Asia Pacific Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Dressings, 2021-2034
  • Table 25: Asia Pacific Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Devices, 2021-2034
  • Table 26: Asia Pacific Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Active Therapies, 2021-2034
  • Table 27: Asia Pacific Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 28: Asia Pacific Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Ulcer Type, 2021-2034
  • Table 30: Latin America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 31: Latin America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Dressings, 2021-2034
  • Table 32: Latin America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Devices, 2021-2034
  • Table 33: Latin America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Active Therapies, 2021-2034
  • Table 34: Latin America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 35: Latin America Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Ulcer Type, 2021-2034
  • Table 37: Middle East & Africa Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 38: Middle East & Africa Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Dressings, 2021-2034
  • Table 39: Middle East & Africa Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Wound-care Devices, 2021-2034
  • Table 40: Middle East & Africa Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by Active Therapies, 2021-2034
  • Table 41: Middle East & Africa Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Diabetic Foot Ulcer Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Diabetic Foot Ulcer Treatment Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Diabetic Foot Ulcer Treatment Market Value Share (%), by Ulcer Type, 2025 & 2034
  • Figure 3: Global Diabetic Foot Ulcer Treatment Market Value Share (%), by Product, 2025 & 2034
  • Figure 4: Global Diabetic Foot Ulcer Treatment Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Diabetic Foot Ulcer Treatment Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Diabetic Foot Ulcer Treatment Market Value (USD billion), by Ulcer Type, 2025 & 2034
  • Figure 7: North America Diabetic Foot Ulcer Treatment Market Value Share (%), by Ulcer Type, 2025
  • Figure 8: North America Diabetic Foot Ulcer Treatment Market Value (USD billion), by Product, 2025 & 2034
  • Figure 9: North America Diabetic Foot Ulcer Treatment Market Value Share (%), by Product, 2025
  • Figure 10: North America Diabetic Foot Ulcer Treatment Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Diabetic Foot Ulcer Treatment Market Value Share (%), by End User, 2025
  • Figure 12: North America Diabetic Foot Ulcer Treatment Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Diabetic Foot Ulcer Treatment Market Value Share (%), By Country, 2025
  • Figure 14: Europe Diabetic Foot Ulcer Treatment Market Value (USD billion), by Ulcer Type, 2025 & 2034
  • Figure 15: Europe Diabetic Foot Ulcer Treatment Market Value Share (%), by Ulcer Type, 2025
  • Figure 16: Europe Diabetic Foot Ulcer Treatment Market Value (USD billion), by Product, 2025 & 2034
  • Figure 17: Europe Diabetic Foot Ulcer Treatment Market Value Share (%), by Product, 2025
  • Figure 18: Europe Diabetic Foot Ulcer Treatment Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Diabetic Foot Ulcer Treatment Market Value Share (%), by End User, 2025
  • Figure 20: Europe Diabetic Foot Ulcer Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Diabetic Foot Ulcer Treatment Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (USD billion), by Ulcer Type, 2025 & 2034
  • Figure 23: Asia Pacific Diabetic Foot Ulcer Treatment Market Value Share (%), by Ulcer Type, 2025
  • Figure 24: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (USD billion), by Product, 2025 & 2034
  • Figure 25: Asia Pacific Diabetic Foot Ulcer Treatment Market Value Share (%), by Product, 2025
  • Figure 26: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Diabetic Foot Ulcer Treatment Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Diabetic Foot Ulcer Treatment Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Diabetic Foot Ulcer Treatment Market Value (USD billion), by Ulcer Type, 2025 & 2034
  • Figure 31: Latin America Diabetic Foot Ulcer Treatment Market Value Share (%), by Ulcer Type, 2025
  • Figure 32: Latin America Diabetic Foot Ulcer Treatment Market Value (USD billion), by Product, 2025 & 2034
  • Figure 33: Latin America Diabetic Foot Ulcer Treatment Market Value Share (%), by Product, 2025
  • Figure 34: Latin America Diabetic Foot Ulcer Treatment Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Diabetic Foot Ulcer Treatment Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Diabetic Foot Ulcer Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Diabetic Foot Ulcer Treatment Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (USD billion), by Ulcer Type, 2025 & 2034
  • Figure 39: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value Share (%), by Ulcer Type, 2025
  • Figure 40: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (USD billion), by Product, 2025 & 2034
  • Figure 41: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value Share (%), by Product, 2025
  • Figure 42: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Diabetic Foot Ulcer Treatment Market Share (%), By Company, 2025